Philips CEO on 4Q Earnings, China, Dividend, Brexit

The transcript discusses the company's financial performance in 2018, highlighting a 5% growth and a 10% increase in order growth, driven by innovation in healthcare. The outlook for 2019 is positive, with expectations of continued momentum and strategic financial decisions like a dividend increase and a new share buyback program. The discussion also covers the robust healthcare market in China, despite a slowdown in consumer demand, and the impact of US-China trade talks on supply chains. Lastly, the company's commitment to the UK market is reaffirmed amidst Brexit-related challenges.

What impact has the economic environment had on the company's share buyback program?

What signs of a slowdown in China did the company observe?

How is the company addressing the challenges posed by the ongoing trade dispute between the US and China?